LIQUMINT Capsule
Peppermint Oil
Beacon Pharmaceuticals Ltd.
| Pack size | |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 11.00 NPR |
Indications
LIQUMINT Capsule is used for:
Irritable bowel syndrome, GI tract spasm
Adult Dose
Oral
Irritable bowel syndrome; Gastrointestinal tract spasm
Adult: Peppermint oil: 0.2 ml tid, increased to 0.4 ml tid if necessary, for up to 3 mth.
Child Dose
Renal Dose
Administration
Contra Indications
Pregnancy; cholecystitis; hepatic damage; children.
Precautions
Hiatal hernia, Pregnancy, lactation.
Pregnancy-Lactation
Interactions
Exacerbation of adverse effects if taken with alcohol; enteric-coated preparations containing peppermint oil should not be taken immediately with antacids.
Adverse Effects
Side effects of Peppermint Oil :
Irritation; erythematous skin rash; headache; bradycardia; muscle tremors and ataxia; heartburn; exacerbation of asthma with wheezing and dypnoea; contact dermatitis, urticaria.
Mechanism of Action
The main constituents of peppermint oil are menthol (29%-48%), menthone (20%-31%) and methyl acetate (3%-10%). It relieves flatulence and colic by relaxation of GI tract smooth muscles.
Note
LIQUMINT Capsule manufactured by Beacon Pharmaceuticals Ltd.. Its generic name is Peppermint Oil. LIQUMINT is availble in Nepal.
Farmaco Nepal drug index information on LIQUMINT Capsule is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.